Characterization of anti-SARS-CoV-2 monoclonal antibodies focusing on antigen binding, neutralization, and FcγR activation via formation of immune complex-Reference-Cited by-同舟云学术

Characterization of anti-SARS-CoV-2 monoclonal antibodies focusing on antigen binding, neutralization, and FcγR activation via formation of immune complex

Published:2023-06-12 Issue:1 Volume:15 Page:
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Tada Minoru¹^ORCID,Aoyama Michihiko¹,Ishii-Watabe Akiko¹

Affiliation:

1. Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, Kawasaki, Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2023.2222874

Reference43 articles.

1. Antibodies to combat viral infections: development strategies and progress

2. Pandemic’s silver lining

3. Tackling COVID-19 with neutralizing monoclonal antibodies

4. Monoclonal antibody therapies against SARS-CoV-2

5. SARS-CoV-2 spike behavior in situ: a Cryo-EM images for a better understanding of the COVID-19 pandemic

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering Fc-effector functions against SARS-CoV-2;Trends in Microbiology;2024-08

2. Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination;Cell Reports Medicine;2024-08

3. An antibody-free evaluation of an mRNA COVID-19 vaccine;Biologicals;2024-02

4. Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination;2024-01-23